BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$478M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Alibaba
BABA
|
+$295M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$995M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$112M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$109M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.6% |
| 2 | Financials | 5.8% |
| 3 | Consumer Discretionary | 5.74% |
| 4 | Healthcare | 5.27% |
| 5 | Communication Services | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CUB
2026
DELISTED
Cubic Corporation
CUB
| $397K | ﹤0.01% |
6,154
-2,612
| -30% | -$153K |
|
|
MDCO
2027
DELISTED
Medicines Co
MDCO
| $397K | ﹤0.01% |
10,875
-7,259
| -40% | -$237K |
|
2028
Vishay Intertechnology
VSH
$5.11B
| $396K | ﹤0.01% |
23,962
-4,027
| -14% | -$71.1K |
|
2029
Quaker Houghton
KWR
$2.95B
| $396K | ﹤0.01% |
1,950
-1,079
| -36% | -$219K |
|
2030
Hancock Whitney
HWC
$6.34B
| $395K | ﹤0.01% |
9,868
-86,298
| -90% | -$3.55M |
|
2031
Otter Tail
OTTR
$3.87B
| $395K | ﹤0.01% |
7,474
-1,698
| -19% | -$86.5K |
|
2032
H.B. Fuller
FUL
$3.24B
| $395K | ﹤0.01% |
8,505
-3,200
| -27% | -$148K |
|
2033
Sabra Healthcare REIT
SBRA
$5.15B
| $394K | ﹤0.01% |
20,024
-47,505
| -70% | -$926K |
|
2034
PUT
F5
FFIV
$23.6B
| $393K | ﹤0.01% |
27
| – | – |
|
2035
Boston Beer
SAM
$1.89B
| $390K | ﹤0.01% |
1,032
-725
| -41% | -$230K |
|
2036
iShares MSCI Malaysia ETF
EWM
$332M
| $390K | ﹤0.01% |
13,107
-320,924
| -96% | -$9.41M |
|
|
ARNA
2037
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $388K | ﹤0.01% |
6,617
-4,856
| -42% | -$251K |
|
2038
Simpson Manufacturing
SSD
$7.99B
| $388K | ﹤0.01% |
5,833
-4,006
| -41% | -$256K |
|
2039
ProShares Short VIX Short-Term Futures ETF
SVXY
$234M
| $387K | ﹤0.01% |
14,370
-282
| -2% | -$7.47K |
|
2040
Semtech
SMTC
$12.4B
| $387K | ﹤0.01% |
8,052
-7,046
| -47% | -$342K |
|
2041
MasTec
MTZ
$23B
| $387K | ﹤0.01% |
7,507
-13,721
| -65% | -$678K |
|
2042
Jack in the Box
JACK
$358M
| $384K | ﹤0.01% |
4,723
-689
| -13% | -$55.7K |
|
2043
AMN Healthcare
AMN
$1.34B
| $384K | ﹤0.01% |
7,075
-4,075
| -37% | -$207K |
|
|
CORE
2044
DELISTED
Core Mark Holding Co., Inc.
CORE
| $384K | ﹤0.01% |
9,661
-2,925
| -23% | -$110K |
|
2045
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
| $384K | ﹤0.01% |
6,900
| – | – |
|
|
CSFL
2046
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $382K | ﹤0.01% |
16,599
-12,728
| -43% | -$299K |
|
|
CARB
2047
DELISTED
Carbonite Inc
CARB
| $380K | ﹤0.01% |
14,600
-2,846
| -16% | -$69.5K |
|
2048
Evercore
EVR
$12B
| $380K | ﹤0.01% |
4,287
+1,401
| +49% | +$125K |
|
2049
Northern Oil and Gas
NOG
$2.61B
| $380K | ﹤0.01% |
19,671
-1,875
| -9% | -$43.4K |
|
2050
Insulet
PODD
$10.1B
| $379K | ﹤0.01% |
3,175
-57
| -2% | -$5.84K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2019 Portfolio in Review
As of Q2 2019, BNP Paribas Financial Markets held 4,663 positions worth $50.2B, up 8.5% from $46.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q2 2019 filing shows 353 new, 1,075 increased, 2,687 reduced and 125 closed positions. Its largest new stake was Cigna: 315,599 shares worth $49.7M. The largest sale was Invesco QQQ Trust, an estimated $995M.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, up from 7.9% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2019 buy was Cigna: 315,599 shares worth $49.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $478M increase.
- BNP Paribas Financial Markets's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $995M.
- BNP Paribas Financial Markets fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $40.4M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $50.2B portfolio in Q2 2019.
- BNP Paribas Financial Markets opened 353 new positions and closed 125 in Q2 2019.
- BNP Paribas Financial Markets's portfolio value rose 8.5% quarter-over-quarter to $50.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2019, filed 30 Jul 2019.